Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. 1996

J W Kolaczynski, and R V Considine, and J Ohannesian, and C Marco, and I Opentanova, and M R Nyce, and M Myint, and J F Caro
Division of Endocrinology and Metabolic Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

We investigated the response of leptin to short-term fasting and refeeding in humans. A mild decline in subcutaneous adipocyte ob gene mRNA and a marked fall in serum leptin were observed after 36 and 60 h of fasting. The dynamics of the leptin decline and rise were further substantiated in a 6-day study consisting of a 36-h baseline period, followed by 36-h fast, and a subsequent refeeding with normal diet. Leptin began a steady decline from the baseline values after 12 h of fasting, reaching a nadir at 36 h. The subsequent restoration of normal food intake was associated with a prompt leptin rise and a return to baseline values 24 h later. When responses of leptin to fasting and refeeding were compared with that of glucose, insulin, fatty acids, and ketones, a reverse relationship between leptin and beta-OH-butyrate was found. Consequently, we tested whether the reciprocal responses represented a causal relationship between leptin and beta-OH-butyrate. Small amounts of infused glucose equal to the estimated contribution of gluconeogenesis, which was sufficient to prevent rise in ketogenesis, also prevented a fall in leptin. The infusion of beta-OH-butyrate to produce hyperketonemia of the same magnitude as after a 36-h fast had no effect on leptin. The study indicates that one of the adaptive physiological responses to fasting is a fall in serum leptin. Although the mediator that brings about this effect remains unknown, it appears to be neither insulin nor ketones.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007657 Ketone Bodies The metabolic substances ACETONE; 3-HYDROXYBUTYRIC ACID; and acetoacetic acid (ACETOACETATES). They are produced in the liver and kidney during FATTY ACIDS oxidation and used as a source of energy by the heart, muscle and brain. Acetone Bodies,Bodies, Acetone,Bodies, Ketone
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids

Related Publications

J W Kolaczynski, and R V Considine, and J Ohannesian, and C Marco, and I Opentanova, and M R Nyce, and M Myint, and J F Caro
July 2008, The Journal of clinical endocrinology and metabolism,
J W Kolaczynski, and R V Considine, and J Ohannesian, and C Marco, and I Opentanova, and M R Nyce, and M Myint, and J F Caro
August 2000, American journal of physiology. Endocrinology and metabolism,
J W Kolaczynski, and R V Considine, and J Ohannesian, and C Marco, and I Opentanova, and M R Nyce, and M Myint, and J F Caro
January 1985, International journal of obesity,
J W Kolaczynski, and R V Considine, and J Ohannesian, and C Marco, and I Opentanova, and M R Nyce, and M Myint, and J F Caro
June 1973, American journal of veterinary research,
J W Kolaczynski, and R V Considine, and J Ohannesian, and C Marco, and I Opentanova, and M R Nyce, and M Myint, and J F Caro
January 2007, Clinical endocrinology,
J W Kolaczynski, and R V Considine, and J Ohannesian, and C Marco, and I Opentanova, and M R Nyce, and M Myint, and J F Caro
December 1988, The Journal of clinical endocrinology and metabolism,
J W Kolaczynski, and R V Considine, and J Ohannesian, and C Marco, and I Opentanova, and M R Nyce, and M Myint, and J F Caro
July 2000, The Journal of clinical endocrinology and metabolism,
J W Kolaczynski, and R V Considine, and J Ohannesian, and C Marco, and I Opentanova, and M R Nyce, and M Myint, and J F Caro
September 1975, Metabolism: clinical and experimental,
J W Kolaczynski, and R V Considine, and J Ohannesian, and C Marco, and I Opentanova, and M R Nyce, and M Myint, and J F Caro
July 2008, The Journal of clinical endocrinology and metabolism,
J W Kolaczynski, and R V Considine, and J Ohannesian, and C Marco, and I Opentanova, and M R Nyce, and M Myint, and J F Caro
June 1985, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!